Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
EMERYVILLE, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today announced that Ron Najafi, Ph.D., Chairman and CEO of NovaBay Pharmaceuticals, will present a corporate and clinical update at the 8th Annual JMP Securities Healthcare Conference, held July 9-10, 2013 in New York City. Ron Najafi and Tom Paulson, Chief Financial Officer of NovaBay, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
Help employers find you! Check out all the jobs and post your resume.
EMERYVILLE, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today announced that Ron Najafi, Ph.D., Chairman and CEO of NovaBay Pharmaceuticals, will present a corporate and clinical update at the 8th Annual JMP Securities Healthcare Conference, held July 9-10, 2013 in New York City. Ron Najafi and Tom Paulson, Chief Financial Officer of NovaBay, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
Help employers find you! Check out all the jobs and post your resume.
